These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27922194)

  • 21. The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines.
    García-Gutiérrez MS; Manzanares J
    J Psychopharmacol; 2010 May; 24(5):757-65. PubMed ID: 19825899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.
    de Haas SL; de Visser SJ; van der Post JP; Schoemaker RC; van Dyck K; Murphy MG; de Smet M; Vessey LK; Ramakrishnan R; Xue L; Cohen AF; van Gerven JM
    J Psychopharmacol; 2008 Jan; 22(1):24-32. PubMed ID: 18187530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.
    Grillon C; Hale E; Lieberman L; Davis A; Pine DS; Ernst M
    Neuropsychopharmacology; 2015 Mar; 40(5):1064-71. PubMed ID: 25430779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The acute and late CNS glutamine response to benzodiazepine challenge: a pilot pharmacokinetic study using proton magnetic resonance spectroscopy.
    Henry ME; Jensen JE; Licata SC; Ravichandran C; Butman ML; Shanahan M; Lauriat TL; Renshaw PF
    Psychiatry Res; 2010 Dec; 184(3):171-6. PubMed ID: 21055907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety.
    Owen RT
    Drugs Today (Barc); 2007 Sep; 43(9):601-10. PubMed ID: 17940637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do alprazolam-induced changes in saccadic eye movement and psychomotor function follow the same time course?
    Kroboth PD; Folan MM; Bauer KS; Tullock W; Wright CE; Sweeney JA
    J Clin Pharmacol; 1998 Apr; 38(4):337-46. PubMed ID: 9590461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
    de Haas SL; de Visser SJ; van der Post JP; de Smet M; Schoemaker RC; Rijnbeek B; Cohen AF; Vega JM; Agrawal NG; Goel TV; Simpson RC; Pearson LK; Li S; Hesney M; Murphy MG; van Gerven JM
    J Psychopharmacol; 2007 Jun; 21(4):374-83. PubMed ID: 17092968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive validity of the potentiated startle response as a behavioral model for anxiolytic drugs.
    Hijzen TH; Houtzager SW; Joordens RJ; Olivier B; Slangen JL
    Psychopharmacology (Berl); 1995 Mar; 118(2):150-4. PubMed ID: 7617801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of fear-potentiated startle by benzodiazepines in C57BL/6J mice.
    Smith KS; Meloni EG; Myers KM; Van't Veer A; Carlezon WA; Rudolph U
    Psychopharmacology (Berl); 2011 Feb; 213(4):697-706. PubMed ID: 20922362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial.
    Levy-Cooperman N; Schoedel KA; Chakraborty B; Blum D; Cheng H
    Epilepsy Behav; 2016 Aug; 61():63-71. PubMed ID: 27315134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic-pharmacodynamic modeling of stimulatory and sedative effects of alprazolam: timing performance deficits.
    Lau CE; Heatherington AC
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1119-29. PubMed ID: 9399984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam.
    Kaplan GB; Greenblatt DJ; Ehrenberg BL; Goddard JE; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 2000 Jun; 20(3):338-46. PubMed ID: 10831021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
    Evans SM; Troisi JR; Griffiths RR
    J Pharmacol Exp Ther; 1994 Nov; 271(2):683-94. PubMed ID: 7965783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of additional oxazepam in long-term users of oxazepam.
    Voshaar RC; Verkes RJ; van Luijtelaar GL; Edelbroek PM; Zitman FG
    J Clin Psychopharmacol; 2005 Feb; 25(1):42-50. PubMed ID: 15643099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam.
    Fries E; Hellhammer DH; Hellhammer J
    Psychoneuroendocrinology; 2006 Nov; 31(10):1278-88. PubMed ID: 17097811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects.
    Kaplan GB; Greenblatt DJ; Ehrenberg BL; Goddard JE; Harmatz JS; Shader RI
    J Clin Pharmacol; 1998 Jan; 38(1):14-21. PubMed ID: 9597554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anxiolytic effect of pregabalin in outpatients undergoing minor orthopaedic surgery.
    Gonano C; Latzke D; Sabeti-Aschraf M; Kettner SC; Chiari A; Gustorff B
    J Psychopharmacol; 2011 Feb; 25(2):249-53. PubMed ID: 19825903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
    Bailey JE; Papadopoulos A; Seddon K; Nutt DJ
    J Psychopharmacol; 2009 Mar; 23(2):117-22. PubMed ID: 18562427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity of late-latency auditory and somatosensory evoked potentials to threat of electric shock and the sedative drugs diazepam and diphenhydramine in human volunteers.
    Scaife JC; Groves J; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 2006 Jul; 20(4):485-95. PubMed ID: 16204321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Overview of the CNS-Pharmacodynamic Profiles of Nonselective and Selective GABA Agonists.
    Chen X; de Haas S; de Kam M; van Gerven J
    Adv Pharmacol Sci; 2012; 2012():134523. PubMed ID: 22363345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.